Recruiting Lung Cancer Studies in Dothan
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors
The goal of this Phase 3 clinical trial is study the safety and efficacy of the nextgen anti-CTLA-4 antibody, gotistobart (ONC-392/BNT316), in patients with metastatic non-small cell lung cancer who h...
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
The Sponsor is developing KB707, a replication-defective, non-integrating herpes simplex virus type 1 (HSV-1)-derived vector that is designed to stimulate an anti-tumor immune response through the pro...
About Lung Cancer Clinical Trials in Dothan
Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.
There are currently 2 lung cancer clinical trials recruiting participants in Dothan, AL. These studies are seeking a combined 800 participants. Research is being sponsored by OncoC4, Inc., Krystal Biotech, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lung Cancer Clinical Trials in Dothan — FAQ
Are there lung cancer clinical trials in Dothan?
Yes, there are 2 lung cancer clinical trials currently recruiting in Dothan, AL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Dothan?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Dothan research site will contact you about next steps.
Are clinical trials in Dothan free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Dothan studies also compensate for your time and travel.
What lung cancer treatments are being tested?
The 2 active trials in Dothan are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.
Data updated March 2, 2026 from ClinicalTrials.gov